Dr Agarwals Eye Hospital Ltd
NSE: BSE: 526783
₹4771.45
(-0.34%)
Mon, 23 Feb 2026, 05:06 am
Market Cap23.14B
PE Ratio32.34
Dividend0.14
Health Services
Medical/Nursing Services
24.5KDr Agarwals Eye Hospital Analysis
dividend
- Dividends per share have increased over the past 10 years.
- Dividends paid are thoroughly covered by earnings (19.4x coverage).
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Dr. Agarwal's Eye Hospital's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Dr. Agarwal's Eye Hospital's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Dr. Agarwal's Eye Hospital is profitable, therefore cash runway is not a concern.
- Dr. Agarwal's Eye Hospital is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (291.7%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 2.2x debt.
- The level of debt compared to net worth has been reduced over the past 5 years (114.1% vs 23.6% today).
- Interest payments on debt are well covered by earnings (EBIT is 3.2x coverage).
- Dr. Agarwal's Eye Hospital's level of debt (23.6%) compared to net worth is satisfactory (less than 40%).
- Dr. Agarwal's Eye Hospital's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Dr. Agarwal's Eye Hospital's long term commitments exceed its cash and other short term assets.
- High level of physical assets or inventory.
management
- The tenure for the Dr. Agarwal's Eye Hospital board of directors is about average.
- The tenure for the Dr. Agarwal's Eye Hospital management team is about average.
- Amar's remuneration is higher than average for companies of similar size in India.
- Amar's compensation has increased by more than 20% in the past year whilst earnings grew less than 20%.
misc
- Dr. Agarwal's Eye Hospital is not covered by any analysts.
- Dr. Agarwal's Eye Hospital has significant price volatility in the past 3 months.
past
- Dr. Agarwal's Eye Hospital has delivered over 20% year on year earnings growth in the past 5 years.
- Dr. Agarwal's Eye Hospital used its assets more efficiently than the IN Healthcare industry average last year based on Return on Assets.
- Dr. Agarwal's Eye Hospital has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Dr. Agarwal's Eye Hospital's earnings growth has exceeded the IN Healthcare industry average in the past year (14.9% vs 14.4%).
- Dr. Agarwal's Eye Hospital's 1-year earnings growth is less than its 5-year average (14.9% vs 30.1%)
- Dr. Agarwal's Eye Hospital's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
value
- Dr. Agarwal's Eye Hospital's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Dr. Agarwal's Eye Hospital's share price is below the future cash flow value, and at a substantial discount (> 40%).
- Dr. Agarwal's Eye Hospital is good value based on earnings compared to the IN Healthcare industry average.
- Dr. Agarwal's Eye Hospital is good value based on earnings compared to the India market.
- 526783 matched the India Market (-14.5%) over the past year.
- BSE:526783 is up 24.3% outperforming the Healthcare industry which returned 5.4% over the past month.
- BSE:526783 is up 24.3% outperforming the market in India which returned 8% over the past month.
- Dr. Agarwal's Eye Hospital is overvalued based on assets compared to the IN Healthcare industry average.
- 526783 underperformed the Healthcare industry which returned 9.1% over the past year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800